Opportunity Information: Apply for PAR 18 479

The NIH funding opportunity titled "Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01 - Clinical Trial Required)" supports rigorous, real-world research aimed at reducing suicide behavior, suicidal thoughts, and non-suicidal self-injury among youth who interact with the juvenile justice system. The core purpose is to fund studies that do more than just identify risk; applicants are expected to test combined approaches that both detect risk early and deliver interventions that can meaningfully prevent harm. Because the mechanism is an R01 and a clinical trial is required, the emphasis is on larger-scale effectiveness testing rather than early feasibility work, with an expectation that the study design will be strong enough to produce actionable evidence for practice.

A central feature of this opportunity is its focus on the many points where youth come into contact with juvenile justice processes, and how those touchpoints can be used to identify and reduce risk. The announcement highlights that opportunities for detection and prevention begin at very early stages such as police interactions and intake interviews, and continue across a wide range of settings including pre-trial detention, juvenile or family court activities, court disposition, and placement settings. Importantly, the FOA recognizes that youth may move between residential placements and community-based supervision or services, so research proposals can target single settings or multiple settings along that pathway, as long as the strategy is plausible and well-integrated into how juvenile justice services are typically delivered.

The FOA strongly encourages intervention strategies that fit the realities of day-to-day juvenile justice and affiliated service environments. That means interventions should be designed to work in typical service settings using staff, infrastructure, and resources that are usually available, rather than relying on highly specialized personnel or unusually intensive supports that would make it hard to replicate. The practical goal behind this is implementation readiness: if an intervention works under study conditions, it should have a realistic chance of being adopted broadly across diverse jurisdictions and program types. In other words, the research is expected to be relevant to scale-up, future uptake, and sustained use, not just short-term success in a highly controlled research setting.

This R01 opportunity was published alongside a companion R34 funding announcement intended for pilot studies that help teams prepare for the larger, more definitive trials envisioned here. In practice, that parallel structure signals a pipeline: the R34 supports preliminary work like refining procedures, testing feasibility, and establishing initial signals, while this R01 is meant for more mature projects that are ready to formally test effectiveness in the field. Applicants considering the R01 are therefore implicitly expected to have a strong foundation for their proposed clinical trial, including clear protocols and a plan for delivering and evaluating the combined detection and intervention approach.

In terms of who can apply, eligibility is broad and includes many types of U.S.-based entities that could realistically conduct justice-related health research. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible categories such as faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIS institutions, among others, reflecting an interest in engaging organizations that serve diverse and often disproportionately impacted communities.

At the same time, there are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In addition, foreign components as defined by NIH policy are not allowed, meaning the funded work must be conducted without foreign components under the NIH Grants Policy framework. These boundaries keep the focus on U.S.-based juvenile justice systems and the service contexts in which U.S. youth receive screening, supervision, detention, court involvement, and related services.

The source details characterize this as a discretionary NIH grant (CFDA 93.242) with a listed award ceiling of $500,000, and the opportunity number is PAR-18-479. The original closing date shown is January 7, 2021, and the FOA was created on December 7, 2017. Overall, the opportunity is geared toward producing solid evidence on what actually works to identify risk and prevent suicide-related outcomes and self-harm among justice-involved youth, with an intentional push toward approaches that can be implemented broadly in routine juvenile justice and community service settings.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01- Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2017-12-07.
  • Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 479

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01 - Clinical Trial Required)

What is the main goal of this NIH funding opportunity?

The opportunity supports rigorous, real-world research to reduce suicide behavior, suicidal thoughts (suicidal ideation), and non-suicidal self-injury among youth who come into contact with the juvenile justice system. Projects are expected to produce actionable evidence that can inform routine practice in juvenile justice and affiliated service settings.

What type of grant mechanism is this?

This is an NIH R01 funding opportunity, and a clinical trial is required.

Is a clinical trial required to apply under this FOA?

Yes. The opportunity is explicitly labeled "R01 - Clinical Trial Required," meaning the proposed research must include a clinical trial component.

Does the FOA emphasize risk identification only, or prevention as well?

The FOA emphasizes that studies should go beyond identifying risk. Applicants are expected to test combined approaches that detect risk early and deliver interventions that meaningfully prevent harm.

What stage of research is this R01 intended to support?

The emphasis is on larger-scale effectiveness testing in real-world conditions rather than early feasibility work. The study design is expected to be strong enough to generate evidence that can be used in practice.

How does this R01 relate to the companion R34 announcement?

This R01 was published alongside a companion R34 intended for pilot studies. The R34 supports preliminary work (such as refining procedures and testing feasibility), while this R01 is intended for more mature projects ready for definitive, field-based effectiveness testing.

What kinds of juvenile justice touchpoints can a project focus on?

The FOA highlights many points of contact where detection and prevention can occur, including early stages like police interactions and intake interviews, as well as pre-trial detention, juvenile or family court activities, court disposition, and placement settings.

Can a project span multiple juvenile justice settings or just one?

Proposals may target a single setting or multiple settings across the pathway of juvenile justice involvement, as long as the approach is plausible and well-integrated with typical juvenile justice service delivery.

Does the FOA recognize that youth move between residential placements and community supervision?

Yes. The FOA notes that youth may move between residential placements and community-based supervision or services, and research strategies can be designed accordingly.

What does the FOA mean by "real-world" research?

The FOA emphasizes rigorous studies conducted in typical service environments, with designs intended to yield evidence that can be used under routine conditions rather than only in highly controlled research settings.

What intervention characteristics does the FOA encourage?

The FOA encourages intervention strategies that fit day-to-day realities of juvenile justice and affiliated service environments, using staff, infrastructure, and resources that are usually available.

Are highly specialized or unusually intensive intervention resources encouraged?

No. The FOA discourages approaches that rely on highly specialized personnel or unusually intensive supports that would be difficult to replicate in typical settings.

Why does the FOA emphasize implementation readiness?

The practical goal is that if an intervention works under study conditions, it should have a realistic chance of being adopted broadly across jurisdictions and program types, with potential for scale-up and sustained use.

Who is eligible to apply?

Eligibility is broad and includes U.S.-based entities such as state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses.

Are organizations serving diverse or disproportionately impacted communities specifically included?

Yes. The FOA explicitly lists additional eligible categories including faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIS institutions, among others.

Are foreign (non-U.S.) institutions eligible to apply?

No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.

Can a U.S. organization include a non-U.S. (non-domestic) component in the project?

No. Non-domestic components of U.S. organizations are not eligible under this FOA.

Are foreign components allowed under NIH policy for this opportunity?

No. The FOA states that foreign components (as defined by NIH policy) are not allowed, so the funded work must be conducted without foreign components under the NIH Grants Policy framework.

What is the opportunity number for this FOA?

The opportunity number is PAR-18-479.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.242.

What is the award ceiling listed in the source details?

The source details list an award ceiling of $500,000.

When was the FOA created, and what closing date is shown?

The FOA was created on December 7, 2017, and the original closing date shown is January 7, 2021.

What outcomes is the research expected to address?

The FOA focuses on reducing suicide behavior, suicidal ideation, and non-suicidal self-injury among youth who interact with the juvenile justice system.

What is the core expectation for the study design?

Because this is an R01 with a required clinical trial, the FOA expects a strong design capable of producing actionable evidence, with clear protocols and a plan to deliver and evaluate a combined detection and intervention approach.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2018

Previous opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 479

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 479) also looked into and applied for these:

Funding Opportunity
NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed) Apply for RFA DE 18 012

Funding Number: RFA DE 18 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional) Apply for PAR 18 487

Funding Number: PAR 18 487
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 027

Funding Number: RFA AG 18 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Deciphering the Molecular Landscape of Lung Aging in Humans (U01 - Clinical Trial Not Allowed) Apply for RFA HL 19 012

Funding Number: RFA HL 19 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed) Apply for PAR 18 497

Funding Number: PAR 18 497
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 026

Funding Number: RFA AG 18 026
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 029

Funding Number: RFA AG 18 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) Apply for PAR 18 432

Funding Number: PAR 18 432
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required) Apply for RFA AG 18 028

Funding Number: RFA AG 18 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) Apply for PAR 18 433

Funding Number: PAR 18 433
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) Apply for PA 18 500

Funding Number: PA 18 500
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional) Apply for RFA AT 18 003

Funding Number: RFA AT 18 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) Apply for PAR 18 513

Funding Number: PAR 18 513
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed) Apply for RFA TW 17 001

Funding Number: RFA TW 17 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $600,000
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional) Apply for PA 18 507

Funding Number: PA 18 507
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01 - Clinical Trial Not Allowed) Apply for RFA AG 18 025

Funding Number: RFA AG 18 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 18 522

Funding Number: PAR 18 522
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional) Apply for PA 18 508

Funding Number: PA 18 508
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional) Apply for PAR 18 543

Funding Number: PAR 18 543
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) Apply for PAR 18 534

Funding Number: PAR 18 534
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 479", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: